SCHEMBL28048968

SCHEMBL28048968

Cc1ccc2cc3c(nc2c1)CCC(N)C3=O

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.45
▸ ACHE P22303 9/20 0.39
▸ BCHE P06276 7/20 0.38
▸ GRIN1 Q05586 7/20 0.38
▸ GRIN2A Q12879 7/20 0.38
▸ CYP1A2 P05177 1/20 0.37
▸ ALDH1A1 P00352 4/20 0.36
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.34
▸ NCK1 P16333 1/20 0.34
▸ BACE1 P56817 1/20 0.34
▸ GAA P10253 2/20 0.34
▸ POLB P06746 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27995127 0.83 ACHE (0.49) ESR1ACHEBCHEGRIN1GRIN2A
SCHEMBL28048966 0.80 BACE1 (0.38) KMT2ABACE1KDM4E
SCHEMBL27995320 0.70 ACHE (0.50) ACHEBCHEGRIN1GRIN2ACYP1A2
SCHEMBL11319351 0.66 ESR1 (0.43) ESR1ACHECYP1A2ALDH1A1NPC1
SCHEMBL15309502 0.63 IL1RN (0.32) KMT2A
SCHEMBL29660577 0.63 CYP1A2 (0.65) ACHECYP1A2ALDH1A1KMT2AHSD17B10
SCHEMBL9755328 0.63 CYP1A2 (0.65) ACHECYP1A2ALDH1A1KMT2AHSD17B10
SCHEMBL27844093 0.62 ANPEP (0.46) ALDH1A1KMT2AHSD17B10GAAPOLB
SCHEMBL22509942 0.61 NCK1 (0.43) ESR1CYP1A2ALDH1A1NPC1RAB9A
SCHEMBL10286621 0.59 ALDH1A1 (0.43) ESR1ACHEBCHEGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103477224-B Blood collection device containing lysophospholipase inhibitor BECTON, DICKINSON AND CO. (US) 2015-12-23 — — CN disclosed
Send feedback